Difference between revisions of "Template:SUIT-001"
(Created page with "700px|link=SUIT-RP2 |SUIT-RP2 {| class="wikitable" border="1" |- ! Step ! Respiratory state ! Pathway con...") Β |
|||
Line 1: | Line 1: | ||
[[File: | [[File:1PM;2D;2c;3U;4G;5S;6Oct;7Rot;8Gp;9Ama;10Tm;11Azd.jpg|700px|link=SUIT-RP1 |SUIT-RP1]] | ||
{| class="wikitable" border="1" | {| class="wikitable" border="1" | ||
|- | |- | ||
Line 8: | Line 8: | ||
|- | |- | ||
| | | 1PM | ||
| Β | | [[PM]](L) | ||
| [[ | | [[N]] | ||
| | | CI | ||
Β | |||
|- | |- | ||
| | | 2D | ||
| [[ | | [[PM]](P) | ||
| | | [[N]] | ||
| | | CI | ||
|- | |- | ||
| | | 2c | ||
| [[ | | [[PM]](P)c | ||
| [[ | | [[N]] | ||
| | | CI | ||
|- | |- | ||
| | | 3U | ||
| [[ | | [[PM]](E) | ||
| [[ | | [[N]] | ||
| | | CI | ||
|- | |- | ||
| | | 4G | ||
| [[ | | [[PGM]](E) | ||
| [[ | | [[N]] | ||
| | | CI | ||
|- | |- | ||
| | | 5S | ||
| [[ | | [[PGMS]](E) | ||
| [[ | | [[NS]] | ||
| | | CI&II | ||
|- | |- | ||
| | | 6Oct | ||
| [[OctPGMS]]( | | [[OctPGMS]](E) | ||
| [[FNS]] | | [[FNS]] | ||
| FAO&CI&II | | FAO&CI&II | ||
|- | |- | ||
| | | 7Rot | ||
| [[ | | [[S]](E) | ||
| [[ | | [[S]] | ||
| | | CII | ||
|- | |- | ||
| | | 8Gp | ||
Β | |||
| [[SGp]](E) | | [[SGp]](E) | ||
| [[SGp]] | | [[SGp]] | ||
Line 74: | Line 62: | ||
|- | |- | ||
| | | 9Ama | ||
| | | | ||
| ROX | | ROX | ||
| ROX | | ROX Β | ||
|- | |- | ||
| | | 10Tm | ||
| [[Tm]](E) | | [[Tm]](E) | ||
| [[CIV]] | | [[CIV]] | ||
Line 86: | Line 74: | ||
|- | |- | ||
| | | 11Azd | ||
| | | Β | ||
| ROX | | ROX | ||
| ROX | | ROX | ||
|} | |} | ||
[[SUIT-011]] | [[SUIT-011]] |
Revision as of 08:38, 11 January 2019
Step | Respiratory state | Pathway control | Pathway to Q |
---|---|---|---|
1PM | PM(L) | N | CI |
2D | PM(P) | N | CI |
2c | PM(P)c | N | CI |
3U | PM(E) | N | CI |
4G | PGM(E) | N | CI |
5S | PGMS(E) | NS | CI&II |
6Oct | OctPGMS(E) | FNS | FAO&CI&II |
7Rot | S(E) | S | CII |
8Gp | SGp(E) | SGp | CII&GpDH |
9Ama | ROX | ROX | |
10Tm | Tm(E) | CIV | CIV |
11Azd | ROX | ROX |
Step | Respiratory state | Pathway control | ET-Complex entry into Q-junction | Comment |
---|---|---|---|---|
1GM | GML | N | CI | GML or GM_L: N-LEAK respiration, NL
NADH-linked substrates glutamate & malate (type N; CI-linked pathway to Q). Non-phosphorylating resting state (LEAK state); Ln in the absence of ADP, ATP, AMP (no adenylates). |
2D | GMP | N | CI | GMP or GM_P: N-OXPHOS capacity, NP
OXPHOS capacity, P (with saturating [ADP]), with NADH-linked substrates glutamate&malate. |
D(c) | GMcP | N | CI | GMcP or GMc_P: Cytochrome c test for quality control
Addition of cytochrome c yields a test for integrity of the mtOM. Stimulation by added cytochrome c would indicate an injury of the mtOM and limitation of respiration in state GMP due to loss of cytochrome c (P, OXPHOS capacity with type N substrates). Cytochrome c is added immediately after the earliest ADP-activation step. |
3S | GMSP | NS | CI&II | GMSP or GMS_P: NS-OXPHOS capacity, NSP
Respiratory stimulation by further addition of succinate, S, to type N substrates, with convergent electron flow in the NS-pathway (CI&II-linked pathway to the Q-junction) for reconstitution of TCA cycle function, in the coupled state as an estimate of OXPHOS-capacity, P. |
4U | GMSE | NS | CI&II | GMSE or GMS_E: NS-ET capacity, NSE
Uncoupler titration (avoiding inhibition by high uncoupler concentrations) to obtain electron transfer (ET) capacity (noncoupled ET-state), as a test for limitation of OXPHOS-capacity by the phosphorylation system (ANT, ATP synthase, phosphate transporter) relative to ET-capacity, E. |
5Rot | SE | S | CII | SE or S_E: S-ET capacity
S-pathway ET-capacity after blocking CI with rotenone. |
6Ama | ROX | ROX: residual oxygen consumption
Rox is due to oxidative side reactions, estimated after addition of Antimycin A (inhibitor of CIII). Rox is subtracted from oxygen flux as a baseline for all respiratory states, to obtain mitochondrial respiration (mt). |